ReachBio Research Labs Revenue and Competitors
Estimated Revenue & Valuation
- ReachBio Research Labs's estimated annual revenue is currently $3.3M per year.
- ReachBio Research Labs's estimated revenue per employee is $155,000
Employee Data
- ReachBio Research Labs has 21 Employees.
- ReachBio Research Labs grew their employee count by 0% last year.
ReachBio Research Labs's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Office and Operations Manager | Reveal Email/Phone |
ReachBio Research Labs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is ReachBio Research Labs?
ReachBio Research Labs provides primary cell biology research tools and specialized contract research services to the drug development and life science research community. With expertise encompassing many aspects of primary cell biology and a special focus on hematopoietic (blood and bone marrow) primary cell systems, ReachBio Research Labs works with customers and clients involved in basic research through multiple areas of pre-clinical and clinical drug development. Our platform is broad and includes predictive and investigative toxicology, immunology, efficacy testing, cell bank development, biomarker selection, flow cytometry/cell sorting, assay development and much more.
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4M | 21 | N/A | N/A |
#2 | $3M | 21 | N/A | N/A |
#3 | $15M | 21 | N/A | N/A |
#4 | $3M | 21 | N/A | N/A |
#5 | $2.1M | 21 | N/A | N/A |